Editors:
- Focus on new developments
- Includes new topics in the field not covered in previous years
- Will represent state-of-the-art research
- Includes supplementary material: sn.pub/extras
Part of the book series: Advances in Experimental Medicine and Biology (AEMB, volume 723)
Buy it now
Buying options
Tax calculation will be finalised at checkout
Other ways to access
This is a preview of subscription content, log in via an institution to check for access.
Table of contents (108 papers)
-
Front Matter
-
AMD: Basic Mechanisms, Inflammation and Immunity
-
Front Matter
-
-
Neuroprotection, Drugs and Novel Protective Therapies
-
Front Matter
-
About this book
Editors and Affiliations
-
University of California, San Francisco, San Francisco, USA
Matthew M. LaVail
-
University of Oklahoma Health Sciences C, Oklahoma City, USA
John D. Ash
-
Health Science Center, Dean A. McGee Eye Inst., University of Oklahoma, OKLAHOMA CITY, USA
Robert E. Anderson
-
Division of Ophthalmology, Cole Eye Institute at the Cleveland Clin, Cleveland, USA
Joe G. Hollyfield
-
Experimental Ophthalmology, University of Zurich, ZURICH, Switzerland
Christian Grimm
Bibliographic Information
Book Title: Retinal Degenerative Diseases
Editors: Matthew M. LaVail, John D. Ash, Robert E. Anderson, Joe G. Hollyfield, Christian Grimm
Series Title: Advances in Experimental Medicine and Biology
DOI: https://doi.org/10.1007/978-1-4614-0631-0
Publisher: Springer New York, NY
eBook Packages: Biomedical and Life Sciences, Biomedical and Life Sciences (R0)
Copyright Information: The Editor(s) (if applicable) and The Author(s), under exclusive license to Springer Science+Business Media, LLC, part of Springer Nature 2012
Hardcover ISBN: 978-1-4614-0630-3
Softcover ISBN: 978-1-4939-4173-5
eBook ISBN: 978-1-4614-0631-0
Series ISSN: 0065-2598
Series E-ISSN: 2214-8019
Edition Number: 1
Number of Pages: LXIV, 864
Topics: Immunology, Ophthalmology, Geriatrics/Gerontology, Gene Therapy